Cabo Verde is broadening access to innovative medicines, Plataforma Media reported on Wednesday, 14 October 2026. The same report states that chronic diseases remain the main cause of mortality in the country.
The two developments were presented together by the outlet, which framed wider availability of newer treatments alongside the persistent burden of long-term illness. Plataforma Media did not, in the headline and summary available, specify which medicines are covered, how eligibility is decided, or which conditions are most affected.
The pairing points to a familiar tension in health policy: expanding the range of treatments on offer while the diseases driving deaths are long-term conditions that require sustained care rather than one-off interventions. According to Plataforma Media, chronic illnesses continue to account for the largest share of deaths in Cabo Verde.
No figures, timelines or implementing institutions were included in the material available, and none are asserted here.
What to watch next: whether Plataforma Media or Cabo Verde's health authorities publish details on which innovative medicines are being added, who qualifies for them, and how the programme is funded.
